Jennifer E. Hibma, PharmD

Pharmacometrician
Pfizer

Jennifer E. Hibma, PharmD, is a DIrector at Pfizer Inc working in the Department of Global Pharmacometrics and Clinical Pharmacology. She earned her PharmD at the University of California at San Francisco (UCSF), where she also completed her Postdoctoral Research Scholar, Clinical Pharmacology Training Fellowship under Dr. Savic and Dr. Giacomini in the UCSF Department of Bioengineering and Therapeutic Sciences. Since joining Pfizer, Jennifer has contributed to several oncology programs submission packages, including lorlatinib, inotuzumab ozogamicin, gentuzumab ozogamicin, dacomitinib, avelumab RCC, and avelumab UC. She has also been the Clinical Pharmacology Lead for the gentuzumab ozogamicin Asset, as well as worked as the Clinical Pharmacology Lead and Clinician on a Phase 1 healthy volunteer study for lorlatinib. She has been a member of ASCPT since 2012 and served as the Chair for the Global Health Community and is currently a member of the Scientific Programming Committee.

Disclosure information not submitted.

Presentation(s):

• Speed Mentoring Session #2 Sponsored by Spaulding

  Thursday, January 13, 2022
  4:15 PM – 5:15 PM ET

• Poster Walk: Model Informed Drug Development: Novel Applications Across Therapeutic Areas

  Wednesday, March 16, 2022
  5:30 PM – 6:00 PM ET